Retatrutide works by activating three pathways—GLP-1, GIP, and glucagon receptors—which together suppress appetite, improve insulin sensitivity, and increase energy expenditure. That’s why the protocol emphasizes slow titration: starting low (around 1–2 mg weekly) lets your body adapt to the strong appetite and GI effects, then gradually increasing every few weeks helps avoid common issues like nausea, reflux, or fatigue. Unlike older GLP-1 drugs, Retatrutide’s glucagon activity can raise metabolism, so weight loss can be more aggressive—but that also increases the risk of muscle loss if calories or protein are too low. In practice, people aim for a steady rate of fat loss while keeping protein high and resistance training consistent. Another key point is staying at the lowest effective dose—once appetite is controlled and weight is trending down, there’s usually no need to keep increasing, since higher doses mainly increase side effects rather than dramatically improving results.
Retatrutide is typically used with a gradual dose-escalation protocol to minimize side effects while maximizing fat loss and metabolic effects. Most approaches start very low (e.g., ~1–2 mg once weekly), then increase every 3–4 weeks (such as 2 → 4 → 6 → up to ~8–12 mg weekly) depending on tolerance, appetite suppression, and side effects like nausea or fatigue. The goal is slow titration rather than rushing to a high dose, since its triple-agonist activity is potent. It’s usually paired with a calorie-controlled diet and adequate protein to preserve muscle, and users often stay at the lowest effective dose that maintains appetite control and steady weight loss rather than pushing maximum dosing.